This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • An open label phase II study to evaluate the effic...
Clinical trial

An open label phase II study to evaluate the efficacy and safety of induction and consolidation therapy with dasatinib in combination with chemotherapy in patients aged 55 years and over with philadelphia chromosome positive (PH+ or BCR-ABL+) acute lympho

Read time: 1 mins
Last updated:7th Jun 2007
To evaluate the efficacy of a dasatinib-based induction and consolidation therapy
Category Value
Study start date 2007-06-07

View full details